Company research / TARA

Protara Therapeutics, Inc. (TARA)

CIK 0001359931 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2014-12-31, Protara Therapeutics, Inc. reported revenue of $2.95M.

Key ratios (year ended 2014-12-31)

-257.1%
Operating margin
-113.4%
Net margin
-4.1%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-11

Headquarters locality: Waltham · View on map

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.